Securities law

Adaptive Biotechnologies Corp Files Form 8-K with US SEC: Annual Meeting Results

Strategic Insights

Jun 12, 2025 — 1 min read

Adaptive Biotechnologies Corporation, a leader in next-generation immunosequencing, has filed a Form 8-K with the US Securities and Exchange Commission (SEC) on June 12, 2025, detailing the results of its annual meeting of shareholders held on June 10, 2025. The meeting saw significant voting participation, with three proposals presented to the shareholders for approval. Each proposal was thoroughly described in the company's definitive proxy statement filed with the SEC on April 29, 2025.

Key Takeaways:

Proposal 1: Chad Robins was elected as the Class III director to the Board of Directors, with 80.95% of shareholders voting in favor (103,695,675 votes) and 19.05% voting against or withholding (24,409,068 votes).
Proposal 2: Shareholders overwhelmingly voted in favor of the advisory request concerning compensation for the Company's 2024 named executive officers, with 98.46% (126,126,999 votes) in favor, 1.23% (1,580,695 votes) against, and 0.31% (397,868 votes) withholding.
Proposal 3: Shareholders ratified Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025, with 99.91% (140,778,854 votes) in favor, 0.08% (113,955 votes) against, and 0.01% (18,714 votes) withholding.

Statistics:

Total number of shares voted: 127,529,560
Proposal 1: 103,695,675 votes for Chad Robins, 819 votes against, and 24,409,068 votes withholding/abstained
Proposal 2: 126,126,999 votes in favor, 1,580,695 votes against, and 397,868 votes withholding/abstained
Proposal 3: 140,778,854 votes in favor, 113,955 votes against, and 18,714 votes withholding/abstained

Sources:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Adaptive Biotechnologies Corporation's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 29, 2025

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients